Poor
Mostly Aligned
Patient Risk:
Medium
Summary
The response includes several grapefruit-related statements that are not supported by the supplied label excerpts (e.g., avoiding all grapefruit including small amounts; exact quantitative thresholds like 2.5x for juice; timing/clearance claims; “one glass” and “half grapefruit” amounts). While the label supports that excessive grapefruit juice can increase atorvastatin concentrations via CYP3A4 inhibition and increase myopathy risk, the response overgeneralizes and adds precise, label-unsupported details.
Category Scores
Accurate Statements
Excessive grapefruit juice consumption can increase plasma concentrations of atorvastatin due to CYP3A4 inhibition (especially with excessive consumption).
7.2 Grapefruit Juice: “Contains one or more components that inhibit CYP 3A4 and can increase plasma concentrations of atorvastatin, especially with excessive grapefruit juice consumption (>1.2 liters per day).”
Grapefruit-related increased atorvastatin exposure can increase the risk of skeletal muscle effects (myopathy).
17.1 Muscle Pain: risk of myopathy is increased when consuming larger quantities (>1 liter) of grapefruit juice. Also 5.1 Skeletal Muscle describes myopathy and increased risk with factors that increase atorvastatin exposure.
Unsupported Statements
All forms of grapefruit (fresh grapefruit, juice, or even small amounts in smoothies or cocktails) should be avoided while taking Lipitor.
Label excerpt provided addresses grapefruit juice (7.2) and increased risk with larger quantities (>1 liter) (17.1); it does not state that all forms and small amounts must be avoided.
One glass of grapefruit juice daily can boost atorvastatin exposure by up to 2.5 times.
No such “up to 2.5 times” quantitative effect is supported by the provided label excerpts.
Even half a grapefruit or 200-250 mL of juice can interfere with atorvastatin.
The provided excerpts give thresholds based on “larger quantities (>1 liter)” (17.1) and “excessive grapefruit juice consumption (>1.2 liters per day)” (7.2); they do not support a half-grapefruit or 200–250 mL threshold.
The effects of grapefruit build over days.
Not supported by the provided label excerpts.
Stopping grapefruit takes time to clear.
Not supported by the provided label excerpts.
Timing does not help much; grapefruit should be avoided entirely while on Lipitor.
The label excerpts do not support a recommendation to avoid grapefruit entirely or a “timing” conclusion.
Contradictions
Low
AI Statement
Heavy drinking (more than 1-2 drinks daily) raises liver strain risk when combined with Lipitor.
Label Reference
5.2 Liver Dysfunction: “LIPITOR should be used with caution in patients who consume substantial quantities of alcohol...” (no numeric threshold provided in supplied text).
Important Omissions
The label excerpts provided specify increased risk particularly with larger quantities of grapefruit juice (>1 liter) and “excessive” grapefruit juice consumption (>1.2 liters/day). The response omits these label-specific qualifiers in favor of blanket avoidance and specific non-label quantifications.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Medium
The response contains multiple absolute/threshold-free advice statements (e.g., avoid all grapefruit forms, small amounts) and precise numeric claims (e.g., “2.5 times,” “half grapefruit,” 200–250 mL) that are not supported by the provided labeling excerpts. This could lead to inappropriate self-restriction or misinterpretation of what constitutes “excessive” intake per label.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Medium |
Recommendation
Mostly Aligned
Primary Issue
Overgeneralization and label-unsupported quantitative/behavioral claims regarding grapefruit (absolute avoidance of all forms/small amounts; specific dose/effect numbers; timing/clearance statements) that are not supported by the provided FDA label excerpts.
Suggested Improvement
Restrict grapefruit-related claims to what the label excerpts support: that grapefruit juice components inhibit CYP3A4 and can increase atorvastatin plasma concentrations, particularly with excessive consumption (>1.2 liters/day), and that risk of myopathy increases with larger quantities of grapefruit juice (>1 liter). Remove blanket “avoid entirely” and remove specific unsupported numeric and timing/clearance statements.